Related Experiment Videos
Limited clinical utility of high-sensitivity plasma C-reactive protein assays
Bruce Campbell1, Tony Badrick, Robert Flatman
1Sullivan Nicolaides Pathology Indooroopilly QLD, Australia. B_Campbell@snp.com.au
Insights
Plasma C-reactive protein (CRP) levels correlate with cardiovascular disease risk. However, significant individual variations in CRP levels make single measurements unreliable for accurate patient risk assessment.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Diagnostics
Background:
- Recent research highlights a link between plasma C-reactive protein (CRP) concentrations and cardiovascular disease (CVD) risk.
- CRP is a key inflammatory marker utilized in assessing CVD risk stratification.
Discussion:
- High intra-individual variability in plasma CRP concentrations poses a significant challenge.
- Single CRP measurements may lead to misclassification of an individual's cardiovascular risk status.
Key Insights:
- The inherent variability of CRP levels complicates its use as a sole diagnostic marker for individual cardiovascular risk.
- Relying on single CRP measurements can lead to inaccurate risk assessments and potentially inappropriate clinical decisions.
Outlook:
- Further research is needed to explore more robust biomarkers or methodologies for accurate CVD risk assessment.
- Investigating methods to account for or mitigate CRP variability in clinical practice is essential for improving patient outcomes.
Abstract:
Many recent studies have shown a relationship between plasma C-reactive protein (CRP) concentrations and risk of cardiovascular disease. However, the intra-individual variation in plasma CRP concentrations is large. Use of plasma CRP measurement in individual patients is likely to result in many being misclassified in their risk status. Use of repeated measurements is not a practical solution to this problem.